C. Cooper

发表

Meilan K. Han, B. Miller, R. Tal-Singer, 2020 .

Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort.

Meilan K. Han, V. Kim, E. Hoffman, 2022, Chronic obstructive pulmonary diseases.

COPD_A_219731 1039..1047

E. Bateman, R. Dawson, R. V. Zyl-Smit, 2020 .

Genetic and non-genetic factors affecting the expression of COVID-19 relevant genes in the large airway epithelium Measures In COPD Study (SPIROMICS),

Jenna, Meilan K. Han, J. Curtis, 2020 .

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort

Meilan K. Han, E. Bleecker, D. Couper, 2019, NPJ biofilms and microbiomes.

Association Between COPD Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort.

V. Kim, D. Couper, R. Kanner, 2022, Journal of the Academy of Consultation-Liaison Psychiatry.

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with 1 Clinical Characteristics: the SubPopulations and Intermediate Outcome Measures in COPD

Benjamin M. Smith, Meilan K. Han, E. Hoffman, 2020 .

Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.

Meilan K. Han, C. Mcevoy, S. Wisniewski, 2022, The New England journal of medicine.

Effect of marijuana smoking on lung function change in older ever tobacco smokers

Meilan K. Han, D. Couper, G. Kinney, 2022, European Respiratory Journal.

Lung2Lung: Volumetric Style Transfer with Self-Ensembling for High-Resolution Cross-Volume Computed Tomography

E. Hoffman, G. Christensen, J. Reinhardt, 2022, 2210.02625.

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS

N. Hansel, R. Barr, N. Alexis, 2022, Respiratory Research.

Prolonged, Physiologically Relevant Nicotine Concentrations in the Airways of Smokers.

S. Rennard, B. Ronish, J. Wells, 2022, American journal of physiology. Lung cellular and molecular physiology.

Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study

E. Hoffman, G. Christensen, J. Reinhardt, 2023, The Lancet. Digital health.

Respiratory Symptoms Items from the COPD Assessment Test Identify Ever‐Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort

Robert Paine, Susan Murray, David Couper, 2017, Annals of the American Thoracic Society.

Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease

I. Barjaktarevic, N. Saiphoklang, C. Cooper, 2022, Diagnostics.

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

F. Martinez, I. Noth, G. Raghu, 2022, BMC pulmonary medicine.

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity

B. Dolezal, I. Barjaktarevic, D. Tashkin, 2022, Sensors.

Validation of Heart Rate Derived from a Physiological Status Monitor-Embedded Compression Shirt Against Criterion ECG

B. A. Dolezal, D. M. Boland, J. Carney, 2014, Journal of occupational and environmental hygiene.

Differences in GOLD 2017 Treatment Group Assignments Between the COPD Assessment Test and Modified Medical Research Council Dyspnea Scale and Their Association with Exacerbations: An Analysis of the SPIROMICS Cohort

V. Kim, N. Hansel, R. Barr, 2019, A24. COPD: THERAPY, IMAGING, AND MOLECULAR MARKERS.

BAL and Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations, Clinical and CT Phenotypes, an Analysis of SPIROMICS

D. Couper, N. Hansel, R. Barr, 2019, A41. COPD: EPIDEMIOLOGY.

Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons.

D. Couper, N. Hansel, R. Kanner, 2023, Chronic obstructive pulmonary diseases.

Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes.

Meilan K. Han, R. Bowler, E. Hoffman, 2020, American journal of respiratory and critical care medicine.

Genome-wide association study of lung function and clinical implication in heavy smokers

E. Hoffman, F. Martinez, E. Bleecker, 2018, BMC Medical Genetics.

Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium

Andrew D. Johnson, Benjamin D. Heavner, May E. Montasser, 2020, medRxiv.

Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD

R. Buhr, I. Barjaktarevic, D. Tashkin, 2023, International journal of chronic obstructive pulmonary disease.

A randomised trial of lung sealant versus medical therapy for advanced emphysema

G. Washko, M. Wahidi, G. Criner, 2015, European Respiratory Journal.

Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS

Meilan K. Han, F. Martinez, D. Couper, 2018, Annals of the American Thoracic Society.

Association of Occupational Exposures and Chronic Obstructive Pulmonary Disease Morbidity

N. Hansel, R. Barr, M. Dransfield, 2023, Journal of occupational and environmental medicine.

A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD

D. Couper, G. Criner, N. Hansel, 2023, Scientific reports.

Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.

Benjamin M. Smith, J. Reinhardt, D. Couper, 2023, Journal of the American Medical Association (JAMA).

Reversible Airflow Obstruction Predicts Future COPD Development in the SPIROMICS Cohort.

E. Bleecker, D. Couper, S. Rennard, 2022, American journal of respiratory and critical care medicine.

Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History.

D. Couper, N. Hansel, R. Barr, 2023, Chronic obstructive pulmonary diseases.

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort

F. Martinez, D. Couper, G. Criner, 2018, Respiratory Research.

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort

Meilan K. Han, J. Curtis, E. Hoffman, 2017, The Lancet. Respiratory medicine.

Clinical implications of low absolute blood eosinophil count in the SPIROMICS COPD cohort.

V. Kim, E. Bleecker, D. Couper, 2021, Chest.

Impact of habitual cocaine smoking on the physiologic response to maximum exercise.

C. Cooper, D. Tashkin, E. Kleerup, 1997, Chest.

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS

J. Curtis, R. Bowler, F. Martinez, 2020, Scientific Reports.

Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage COPD.

D. Couper, R. Barr, R. Paine, 2022, American journal of respiratory and critical care medicine.

Changes in Lung Volumes with Spirometric Disease Progression in COPD.

J. Hokanson, D. Couper, G. Criner, 2023, Chronic obstructive pulmonary diseases.

LungViT: Ensembling Cascade of Texture Sensitive Hierarchical Vision Transformers for Cross-Volume Chest CT Image-to-Image Translation.

E. Hoffman, G. Christensen, J. Reinhardt, 2022, IEEE transactions on medical imaging.

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort

E. Bleecker, D. Couper, N. Hansel, 2021, npj Biofilms and Microbiomes.

Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts

W. Bailey, R. Casaburi, B. Make, 2017, Journal of General Internal Medicine.

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study

Meilan K. Han, R. Bowler, V. Kim, 2017, BMJ Open Respiratory Research.

Ambient Air Pollution Exposure and Sleep Quality in COPD.

V. Kim, D. Couper, N. Hansel, 2023, Chronic obstructive pulmonary diseases.